
|
|
Gentle Giant Award
The Pituitary Network Association's prestigious Gentle Giant Award is given in honor
of those that have presented longstanding advocacy, outstanding contribution and
dedication to pituitary patient care, education, and pituitary medicine. Great strides
in pituitary knowledge, diagnosis, and treatment have been achieved by these "Gentle
Giants".

|
SCOTT HAMILTON
Olympic Gold Metal Skater
Honorary Chairman, PNA Board of Governors
2008 Gentle Giant Award Recipient

|
On the second night of the 2008 December in the Desert Conference at the Rancho
Las Palmas Resort & Spa, in Rancho Mirage, CA, the PNA presented its Gentle Giant
Award to Mr. Scott Hamilton. Scott Hamilton is a world class athlete but he's also
a survivor of cancer and pituitary disease. Hamilton was diagnosed with testicular
cancer in 1997, and learned he had a benign pituitary brain tumor (a craniopharyngioma)
in November of 2004. We are excited to have a man whose skill, warmth and courage
have inspired so many people throughout his career, be honored as the 2008 Gentle
Giant Award recepient.
One of the most popular male figure skating stars in the world, Scott Hamilton is
also a network TV skating commentator, an actor, performer, producer, Emmy Award
nominee, best-selling author, role model, humanitarian, philanthropist, and a cancer
and brain tumor survivor.
As a humanitarian and philanthropist he avails himself to any plight that will improve
mankind. As a cancer and brain tumor survivor, he is constantly reminding others
that, with fortitude and determination, anything is possible.
When he is not performing or participating in a wide variety of charitable events,
or acting as an official spokesperson for Target House at St. Jude Children's Hospital
in Memphis, Tennessee, as well as his own *Scott Hamilton C.A.R.E.S. Initiative
(Cancer Alliance for Research, Education and Survivorship) at the Cleveland Clinic
Taussig Center in Cleveland, Ohio, or promoting his web site Chemocare.com (in conjunction
with the Cleveland Clinic and CARES), the Honorary Chairman of the Board of Governors
for the Pituitary Network Association, or serving on the Board of Directors for
Special Olympics, Scott can be found on the golf-course and enjoys spending time
with his wife Tracie and their sons Maxx and Aidan at their home in Tennessee.
|
George P. Chrousos, M.D.
Professor and Chairman
Athens University Medical School
Children's Hospital Aghia
2006 Award Recipient
|
On the second night of the 2006 December in the Desert Conference, the PNA presented
its Gentle Giant Award to Dr. George Chrousos. Dr. Chrousos is a professor at the
University of Athens and a leading expert on Cushing's disease and psychiatric disorders
caused by hormonal imbalances. He is the former chief of Pediatric Endocrinology
at the National Institutes of Health.
The keynote speaker for the ceremony was Nobel Laureate Dr. Roger Guillemin, who
talked about the history of acromegaly. Guillemin, a distinguished professor at
the Salk Institute for Biological Studies in San Diego, California, won the Nobel
Prize in 1977 for discoveries that laid the foundation for brain hormone research.
His work brought to light an entirely new class of substances shown to be important
for the regulation of growth, development, reproduction and responses to stress.
We are proud to count both Drs. Chrousos and Guillemin as members and supporters
of the PNA.
George P. Chrousos is Professor and Chairman of Pediatrics at the Athens University
Medical School. He has focused his research on the hypothalamicpituitary- adrenal
(HPA) axis and has extensively studied the neuroendocrine alterations associated
with mood disorders, sleep, pain perception, and immune function. His laboratory
is recognized worldwide for its work on the glucocorticoid signaling system, diseases
of the HPA axis, such as Cushing's syndrome, and the physiologic and molecular mechanisms
of stress.
Dr. Chrousos has contributed immensely to the biomedical literature and his work
has provided new insights into a variety of chronic complex disorders. He has written
over 1000 scientific papers and his work has been cited in about 35,000 other scientific
articles, an irrefutable testimony to the importance and influence of his research.
He is one of the most cited physician scientists in the world (ISI highly cited).
His work has educated a broad community of physicians and scientists around the
world. As a mentor, he has helped to develop the careers of many young physicians
and scientists, several of whom are now professors and chairpersons in Europe, the
United States, Australia and Latin America. An outstanding teacher, he has had a
number of visiting professorships and given prestigious lectures throughout the
world.
Dr. Chrousos has received numerous national and international awards for his work,
including election to membership in the prestigious American Society of Clinical
Investigation and the Association of American Physicians. He was recently inducted
as a master of both the American College of Endocrinology and the American College
of Physicians.
"Dr. George Chrousos has served as a leader and role model of Physician-Scientists
in the field of pituitary medicine. His investigations have been carried out with
a precise scientific approach, but always based on clinically-relevant questions.
His interest in the interactions between the brain and the hormonal milieu has led
him on a focused journey through the territory of the pituitary and its target,
the adrenal, to clarify for patients and clinicians alike the importance of endocrinology
in psychosocial medicine. For this body of work, his dedication and support of patients
throughout the world, the PNA owes him a debt of gratitude."
- Dr. Sylvia Asa
"I have known George for almost 20 years and there is no doubt that he is one of
the premier researchers all time in the field of pediatric endocrinology. During
his tenure at the NIH, he brought adrenal gland research to a new level."
"I have to thank George for two things in particular. First, when I was at UCLA,
he interviewed for our vacant Division Chief position, but, for whatever reasons,
did not take the position. That was good news for me because I got the position.
I am forever indebted. Second, one of my recent fellowship graduates, Dr. Maria
Karantza, a Greek national, recently returned home to Athens and took a position
with George. Maria was one of the best fellows I ever had and I have entrusted George
with the further advancement of her career. I know that she is in great hands."
- Dr. Mitchell Geffner
"Few Physician-Scientists have come close to the term. Dr. Chrosous embodies the
descriptor better than anyone else I know. For decades Dr. Chrosous has made his
mark by leading a world-class research team. However, what has set him apart was
a constant eye for the clinically relevant. Always focused, introspective but with
utmost humility, he has provided us with an outstanding role model."
- Dr. Shereen Ezzat
"Chrousos in ancient as well as modern Greek, means gold. George Chrousos, our gold
standard in endocrinology!"
- Dr. Roger Guillemin
"If there is such a category, Dr. Chrousos has earned the designation of both a 'patient's
doctor' as well as a 'doctor's doctor'! His devotion to the plight of children and
adult patients with pituitary/hormonal disorders is by now legendary, world-wide!
What is only known in the medical community, is that his devotion to the healing
arts is such that he gathers the universal admiration and respect of other world
class physicians. Having observed him in many countries, I know a good man when
I see one. He is indeed a Gentle Giant."
- Robert Knutzen
|
Sylvia L. Asa, M.D., Ph.D.
Professor, Department of Laboratory Medicine and Pathobiology
University of Toronto
Pathologist-in-Chief
University Health Network and Toronto Medical Laboratories
2005 Award Recipient
|
Dr. Asa has a distinguished career in Medicine, and her work in Pituitary and Thyroid
Adenomas and Carcinomas has clearly marked her as a distinguished academician and
researcher. However, her humanity, exceptional grace to those in need of help, and
an extraordinary insight into the "Healing Arts", puts her on a level "above and
beyond" the ordinary call of duty. The PNA is very proud to be able to honor the
Chair of its Scientific Advisory Panel, Former President of the PNA, and exceptional
co-worker with the Gentle Giant Award for 2005.
Dr. Asa is the Medical Director of Toronto Medical Laboratories and Pathologist-in-Chief
at the University Health Network, a Professor in the Department of Laboratory Medicine
and Pathobiology at the University of Toronto. She received her medical and post-doctorate
degrees from the University of Toronto and completed her internship in internal
medicine at Toronto General Hospital and the University of Toronto. She received
her residency training in pathology at Mount Sinai Hospital, St. Michael's Hospital
and the Toronto General Hospital, all affiliated with the University of Toronto.
She subsequently was a research fellow in the Department of Pathology at St. Michael's
Hospital and the University of Toronto.
|
Shereen Ezzat, M.D., FRCP(C), FACP
Professor of Medicine & Oncology
Head, Endocrine Oncology Site Group
Princess Margaret Hospital,
University Health Network
2005 Award Recipient
|
Dr. Ezzat for the past 15 years has not only become a valued and highly respected
member of the Pituitary Endocrine Community with his many contributions to research,
medical literature and knowledge, but also a "Guiding Light" for the Pituitary Network
Association. As our "Editor in Chief" for these 15 years, a prolific and most gifted
communicator and teacher, he has enriched the lives of patients, world-wide. He
has become a friend and sounding board to a large number of patients and PNA staff
members, always generous with his time and knowledge. We are honored to know him
and proudly proclaim him a "Gentle Giant" for 2005. His past service as President
and his current service on our Scientific Advisory Panel are deeply appreciated.
Dr. Ezzat obtained his medical degree from the University of Manitoba, completed
his residency training at the Univiversity of Toronto, Mount Sinai Hospital, and
his post-doctoral research training in molecular oncology at Cedars-Sinai-UCLA School
of Medicine in Los Angeles.
Dr. Ezzat has authored or co-authored more than 180 original research articles and
30 invited review articles, and he has delivered more than 100 invited lectures.
He supervises undergraduate, medical, and graduate students, as well as postdoctoral
fellows. He teaches a number of courses, including physiology, biochemistry, developmental
biology, and endocrinology.
Dr. Ezzat serves as an Editorial Board member for a number of journals including
Endocrinology, Journal of Clinical Endocrinology & Metabolism, Journal of Endocrinology,
Endocrine Practice, and BMJ-Endocrine. He is a regular reviewer for the New England
Journal of Medicine and the Annals of Internal Medicine.
Dr. Ezzat has been honored with numerous awards. Most recently, he received the
2008 Senior Scientist award from the Royal College of Physicians & Surgeons of Canada,
the 2006 International Endocrine Society Research Mentor Award, the 2005 Gentle
Giant Award, the Pharmacia & Upjohn International Award for Excellence in Published
Endocrine Research. He is also the recipient of the Premier's Research Excellence
Award, the Novartis Canada Senior Investigator Award, and the Allan Bruce Robertson
Young Investigator Award. His work, focusing mainly on the molecular genetics of
endocrine cancer, has been funded by the CIHR, the Cancer Research Society, and
the Sackler Foundation. He belongs to a number of professional societies, including
the Endocrine Society, Federation of American Societies for Experimental Biology
(FASEB), the Pituitary Society, the American College of Physicians, and the Royal
College of Physicians & Surgeons of Canada.
Dr. Ezzat is equally committed to patient care and education. In 1990, he co-founded
the Pituitary Network Association and has been the Editor-in-Chief of the Pituitary
Tumor Patient Resource Guide, a reference book designed for patients that has received
world-wide recognition and is now in its fourth edition. He has filled a similar
role with the Thyroid Cancer Survivor (Thyrvor) and the North American Carcinoid
Group.
|
Edward R. Laws, Jr., M.D., FACS
Director, Pituitary/Neuroendocrine Center;
Interim Director, Neuro-oncology
Brigham & Women's Hospital
2004 Award Recipient
|
Edward R. Laws, Jr., M.D., FACS, former professor and chair, Department of Neurosurgery,
The George Washington University, and professor of Neurosurgery and of Medicine,
University of Virginia, was selected as the Pituitary Network Association's "Gentle
Giant 2004." The award was presented on May 5, 2004, in conjunction with the American
Association of Neurological Surgeons Convention in Orlando, Florida.
Dr. Laws received his bachelor's degree with honors from Princeton University and
then attended the Johns Hopkins School of Medicine, where he completed his surgical
internship and neurosurgical residency before joining the faculty of the medical
school with a primary appointment in pediatric neurosurgery. In 1972, he joined
the staff of the Mayo Clinic in Rochester, Minnesota, where he ultimately become
professor of Neurosurgery and developed major interests in pituitary and epilepsy
surgery, along with a continuing interest in the metabolism and pathophysiology
of primary brain tumors.
In 1978, Dr. Laws became professor and chairman of the Department of Neurosurgery
at GW, and in 1992, he joined the faculty of the University of Virginia as professor
of Neurosurgery and of Medicine, establishing a Neuro-Endocrine Center there. During
his surgical career, he has operated on more than 5,000 brain tumors, of which 4,200
have been pituitary lesions.
Dr. Laws has served as president of the Congress of Neurological Surgeons, editor
of Neurosurgery, chairman of the Board of Trustees of the Foundation for International
Education in Neurosurgery, director of the American Board of Neurological Surgery,
president of the American Association of Neurological Surgeons and president of
the Pituitary Society. He has authored more than 400 scientific papers and book
chapters, and, with Andrew Kaye, is co-editor of the encyclopedic volume, Brain
Tumors.
Currently, Dr. Laws in president-elect of the American College of Surgeons, president
of the World Federation of Neurological Societies, chairman of the Board of Regents
of the American College of Surgeons and is chair of the Residency Review Committee
for Neurosurgery. He remains actively involved in brain tumor and neuroendocrine
research.
The George Washington University Medical Center is an internationally recognized
interdisciplinary academic health center, which has consistently provided high quality
medical care in the Washington, D.C. metropolitan area since 1825. The Medical Center
comprises the School of Medicine and Health Sciences, the 11th oldest medical school
in the country; the School of Public Health and Health Services, the only such school
in the nation's capital; GW Hospital, jointly owned and operated by a partnership
between The George Washington University and Universal Health Services, Inc.; and
GW Medical Faculty Associates, an independent faculty practice plan.
|
Peter Snyder, M.D.
Professor of Medicine University Of Pennsylvania, PA
2003 Award Recipient
|
The Second Annual Gentle Giant Award Dinner was held Friday, June 20, 2003, at the
University of Pennsylvania's Museum of Archeology and Anthropology amid treasures
befitting this year's award recipient Dr. Peter J. Snyder.
For nearly 40 years, Dr. Snyder has been a leader in male reproductive endocrinology.
Having obtained his medical degree from Harvard Medical School and his board certification
in Internal Medicine, Endocrinology, Diabetes and Metabolism, Dr. Snyder is Professor
of Medicine at the University of Pennsylvania and a member of the Division of Endocrinology
at the Hospital of the University of Pennsylvania. A distinguished lecturer and
extensively published author, Dr. Snyder is one of the world's leaders in pituitary
endocrine research. His interests include the effects of testosterone and growth
hormone on bone and muscle and the pathogenesis of pituitary tumors, especially
gonadotroph (non-functional) adenomas.
Never will you find a more modest human being than Dr. Peter J. Snyder. His brilliance
has filled volumes of books and journals yet he remains shy and soft-spoken, allowing
his work to be driven by compassion and tenacity not accolades. For this, The Pituitary
Network Association is very proud to have chosen Dr. Peter J. Snyder as the recipient
of the 2003 Gentle Giant Award in honor of his longstanding advocacy of improved
treatment for patients, and his outstanding contribution and dedication to pituitary
patient care, education, and the field of pituitary endocrine medicine.
|
Charles B. Wilson, M.D.
University Of California, San Francisco
2002 Award Recipient
|
UCSF Professor Emeritus Charlie Wilson was honored on Saturday February 2nd 2002,
in recognition of his outstanding contributions and dedication to the field of pituitary/endocrine
medicine at the First Annual Gentle Giant Award Dinner.
The event was held at the Delancey Street Foundation, Town Hall, 600 Embarcadero,
San Francisco.
Wilson is recognized worldwide for his surgical skills and commitment toward research
and medical advancement. He has served on local, state and national committees and
has served as a consultant in health care. Most notably, Wilson popularized and
perfected the transsphenoidal approach to pituitary tumors by proving its effectiveness
and safety. He has performed more than 3,300 transphenoidal surgeries for a pituitary
tumor at UCSF Medical Center. His skills in surgery as well as in research have
helped patients all over the world.
In 1968, Wilson was invited to UCSF to serve as professor and chairman of the neurosurgery
division and to establish a laboratory for the study of brain tumors. By 1970, he
had established the department of neurological surgery and the Brain Tumor Research
Center (BTRC), a national cancer research center, which has been continuously funded
by the National Institutes of Health since 1971. As director of the BTRC, Wilson
realized an integrally related program of basic science and clinical research. The
BTRC treats over 500 brain tumor patients each year, contributes extensively to
basic and applied research in neuro-oncology, trains numerous neuro-oncologists
and clinical and basic scientists in brain tumor research, and provides continuing
education and consultation for private practitioners.
During the past few years, Wilson has redirected his primary focus to the organization
and delivery of health care, in particular the challenges facing academic medicine
in response to an environment of new market forces. He served as Senior Associate
on Medical Affairs to the President of the University of California, in addition
to his clinical practice at UCSF. In 1996, he obtained a Master's degree in Health
Administration.
Wilson resigned as chairman of the department of neurological surgery and director
of the BTRC in April 1997 to pursue these interests. In July of that year, he was
appointed Senior Research Fellow at the nonprofit independent research organization,
Institute for the Future in Menlo Park and San Francisco. He now serves as its director,
providing expertise in areas such as novel medical technologies, academic medical
centers, the future of health care and the impact of genetics and genomics on health
and health care. Wilson authored an article, "The Hospital of the Future," which
appeared in the September 2001 issue of UCSF Magazine.
Wilson earned his medical degree and received neurosurgical training at Tulane University,
where he graduated first in his class in 1954.

|
|
Gentle Giant Recipients
|